CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Buprenorphine transdermal patch

Last Updated: October 15, 2010
Result type: Reports
Project Number: S0211
Product Line: Common Drug Review

Generic Name: Buprenorphine transdermal patch

Brand Name: BuTrans

Manufacturer: Purdue Pharma

Indications: Pain, persistent (moderate intensity)

Submission Type: New

Project Status: Cancelled